Consistent with our findings, Goard CA and colleagues [6] also reported that sensitivity of breast cancer cell lines to fluvastatin treatment was inversely correlated with basal HMGCR mRNA and protein expression levels. The gene discussed is HMGCR; the disease is breast carcinoma.